A method for inhibiting cancer development by fatty acid synthase inhibitors

Details for Australian Patent Application No. 2003287380 (hide)

Owner The John Hopkins University Fasgen LLC

Inventors Townsend, Craig A.; Jaffee, Elizabeth M.; Kuhhajda, Francis Paul,

Agent Peter Maxwell & Associates

Pub. Number AU-B-2003287380

PCT Number PCT/US2003/0346

PCT Pub. Number WO2004/041189

Priority 60/422,746 31.10.02 US

Filing date 31 October 2003

Wipo publication date 7 June 2004

Acceptance publication date 28 May 2009

International Classifications

A61K 31/34 (2006.01) - having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide

A61K 31/00 (2006.01)

Event Publications

1 April 2004 Complete Application Filed

  Priority application(s): 60/422,746 31.10.02 US

1 July 2004 Application Open to Public Inspection

  Published as AU-B-2003287380

28 May 2009 Application Accepted

  Published as AU-B-2003287380

18 June 2009 Alteration of Name

  The name of the applicant has been altered to Fasgen LLC; The Johns Hopkins University

9 July 2009 Corrigenda

  Applications Accepted - Name Index Under the name Fasgen LLC and The Johns Hopkins University, Application No. 2003287380, under INID(72) correct the co-inventor name to Kuhajda, Francis Paul

24 September 2009 Standard Patent Sealed

26 May 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003287381-Composition for the treatment of macular degenration

2003287379-SYSTEM AND METHOD FOR COMMUNICATING WITH A VOLTAGE REGULATOR